Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ocuphire Pharma
Ocuphire Pharma
(OCUP)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ryzumvi
Phentolamine
2023-09-25
2034-2039
Necrosis
,
Extravasation of diagnostic and therapeutic materials
,
Malignant hypertension
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Phentolamine
hypertension
,
ocular hypertension
,
glaucoma
,
open-angle glaucoma
,
pathologic dilatation
,
dilatation
,
mydriasis
,
presbyopia
,
vision disorders
,
night blindness
,
mesopic vision
Clavulanate
depression
,
major depressive disorder
,
depressive disorder
,
erectile dysfunction
Alfacalcidol
vision disorders
,
pathologic dilatation
,
dilatation
,
mydriasis
Lactams
erectile dysfunction
APX3330
macular edema
,
retinal diseases
,
diabetic retinopathy
Demand
erectile dysfunction
Mydfrin
pathologic dilatation
,
dilatation
,
mydriasis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use